Galaxy Biomedical Investment Co. Ltd. A | |
Stock Exchange | Shenzhen Stock Exchange |
EPS |
CNY0.63 |
Market Cap |
CNY2.68 B |
Shares Outstanding |
698.45 M |
Public Float |
554.07 M |
Address |
Galaxy Software Technology Park Beihai Guangzi Zhuang 536000 China |
Employees | - |
Website | http://www.g-biomed.com |
Updated | 07/08/2019 |
Galaxy Biomedical Investment Co., Ltd. engages in the provision of investment in bio-pharmaceutical industry, transmission and distribution system industry, and electronic information industry. The company focuses on biotechnology and build its pharmaceutical and medical service industry structure; production and sale of transformer products; and manufacture of resistors, sensors, brake resistor box, radio frequency components, and potentiometers. The company was founded on June 20, 1993 and is headquartered in Beihai, China. |